Abordagem da Hemostase e Anticoagulação no Contexto da Infeção Por SARS-CoV-2

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020 (in press). doi: 10.1111/jth.14768.

Mendes J, Mergulhão P, Froes F, Paiva JA, Gouveia J. Recomendações da Sociedade Portuguesa de Cuidados Intensivos e Grupo Infeção e Sépsis para a abordagem do COVID-19 em Medicina Intensiva. Rev Bras Terap Intensiva 2020 (in press). doi.org/10.5935/0103-507X.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 (in press). doi: 10.1111/ JTH.14817.

Tachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020 (in press). doi: 10.1111/JTH.14810.

Gralinski LE, Bankhead A, Jeng S et al. Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. mBio. 2013; 4: e00271-e313.

Wilson AJ, Martin DS, Maddox V, Rattenbury S, Bland D, Bhagani S, et al. Thromboelastography in the Management of Coagulopathy Associated with Ebola Virus Disease. Clin Infect Dis. 2016;62:610–2.

Beeching NJ, Fletcher TE, Fowler R. BMJ Best Practice COVID-19. [accessed May 2020] Available from: http://bestpractice.bmj.com.

Webinar SETH (Sociedad Española de Trombosis y Hemostais)· Coagulación, Anticoagulación y COVID-19: lo que te interesa conocer. MODERA- DOR: Dr. José A. Páramo Fernández, Serviço hematologia CUN, Pamplona. Oradores: CORONAVIRUS Y COAGULOPATÍA-Dr.a Olga Gavín Sebastián, INTERPRETACIÓN LABORATORIO DE HEMOSTASIA-Dr. Joan Carles Re- verter Calatayud, DOCUMENTO SETH SOBRE ANTICOAGULANES Y COVID-19-Dr. Pere Domènech Santasusana, PREVENCIÓN Y TRATAMIENTO DE LA COAGULOPATÍA ASOCIADA A COVID-19-Dr. Víctor Jiménez Yuste. Emitido em 06.04.2020 às 13h. https://www.covid-19.seth.es/coagula- cion-anticoagulacion-y-covid-19-lo-que-te-interesa-conocer/

Llau J.V., Ferrandis R, Sierra P, Hidalgo F, Cassinello C, Gómez-Luque A, Quintana M, Amezaga R, Gero M, Serrano A, Marcos P. Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19. SEDAR- -SEMICYUC consensus recommendations on the management of hae- mostasis disorders in severely ill patients with COVID-19 infection. Rev.Esp. Anesthesiol. Reanim. 2020: 23:1-16. doi.org/10.1016/j.redar.2020.05.007

Carvalho M, Rodrigues A, Gomes M, Carrilho A, Robalo Nunes A, Orfão R,et al. Interventional Algorithms for the controlo of coagulopathic bleeding in surgical, trauma and pospartum settings. Clin Applied Thrombosis/Hemostasis. 2014:1-17.